RSS-Feed abonnieren
DOI: 10.1055/s-0028-1087521
Cyclohepta[de]naphthalenes and the Rearranged Abietane Framework of Microstegiol via Nicholas Reaction Chemistry
Publikationsverlauf
Publikationsdatum:
15. Januar 2009 (online)
![](https://www.thieme-connect.de/media/synlett/200902/lookinside/thumbnails/10.1055-s-0028-1087521-1.jpg)
Abstract
Nicholas reactions on 2,7-dioxygenated naphthalenes give C-1 monosubstitution and C-1/C-8 disubstitution in most cases. From γ-carbonyl cation monocondensation product 3b or alkyne-unsubstituted dicondensation product 4a, cyclohepta[de]naphthalenes bearing no substituents, gem-dimethyl substituents, and a ketone function, and the rearranged abietane framework of microstegiol may be prepared.
Key words
carbocations - alkyne complexes - transition metals - electrophilic aromatic substitution - ring closure - tautomerism
-
1a
Green JR. Chem. Commun. 1998, 1751 -
1b
Patel MM.Green JR. Chem. Commun. 1999, 509 -
1c
Lu Y.Green JR. Synlett 2001, 243 -
1d
Green JR. Synlett 2001, 353 -
1e
Ding Y.Green JR. Synlett 2005, 271 -
1f
Djurdjevic S.Green JR. Org. Lett. 2007, 9: 5505 - For recent reviews on the Nicholas reaction, see:
-
2a
Diaz DD.Betancort JM.Martin VS. Synlett 2007, 343 -
2b
Teobald BJ. Tetrahedron 2002, 58: 4133 -
2c
Green JR. Curr. Org. Chem. 2001, 5: 809 - 3
Vizniowski CS.Green JR.Breen TL.Dalacu AV. J. Org. Chem. 1995, 60: 7496 - For γ-carbonyl cation equivalents by way of iron allyl cations, see:
-
4a
Green JR.Carroll MK. Tetrahedron Lett. 1991, 32: 1141 -
4b
Zhou T.Green JR. Tetrahedron Lett. 1993, 34: 4497 -
4c
Charlton MA.Green JR. Can. J. Chem. 1997, 75: 965 -
4d
Enders D.Jandeleit B.Von Berg S. Synlett 1997, 421 ; and references therein - For γ-carbonyl cation equivalents by way of π-allyl-palladium complexes, see:
-
5a
Nemoto T.Fukuda T.Matsumoto T.Hitomi T.Hamada Y. Adv. Synth. Catal. 2005, 347: 1504 -
5b
Nemoto T.Fukuda T.Hamada Y. Tetrahedron Lett. 2006, 47: 4365 ; and references therein - For γ-carbonyl cation equivalents by way of carbonyl-substituted cyclopropanes, see:
-
6a
Lifchits O.Alberico D.Zakharian I.Charette AB. J. Org. Chem. 2008, 73: 6838 ; and references therein -
6b
Harrington PA.Kerr MA. Tetrahedron Lett. 1997, 38: 5949 -
6c
Danishefsky S. Acc. Chem. Res. 1979, 12: 66 - 7
Ulubelen A.Topcu G.Tan N.Lin L.-J.Cordell GA. Phytochemistry 1992, 31: 2419 - 8
Topcu G.Ulubelen A. J. Nat. Prod. 1996, 59: 734 - 9
Chyu C.-F.Lin H.-C.Kuo Y.-H. Chem. Pharm. Bull. 2005, 53: 11 -
10a
Ulubelen A.Topçu G.Chai H.-B.Pezzuto JM. Pharaceut. Biol. 1999, 37: 148 -
10b
Ulubelen A.Öksuz S.Kolak U.Bozok-Johannson C.Çelik C.Voelter W. Planta Med. 2000, 66: 458 - 11
Topcu G.Altiner EN.Gozcu S.Halfon B.Aydogmus Z.Pezzuto JM.Zhou B.-N.Kingston DGI. Planta Med. 2003, 69: 464 -
12a
Richer J.-C.Pépin Y. Can. J. Chem. 1965, 43: 3443 -
12b
Merchant JR.Upasani RB. Indian. J. Chem, Sect. B.; Org. Chem. Incl. Med. Chem. 1981, 20: 711 -
12c
Alder RW.Bryce MR.Goode NC.Miller N.Owen J. J. Chem. Soc., Perkin Trans. 1 1981, 2840 -
12d
Gorelik AM.Reznichenko AV.Andronova NA.Luk’yanets EA. Zh. Org. Khim. 1983, 19: 199 -
12e
Haddon RC.Hirani AM.Kroloff NJ.Marshall JH. J. Org. Chem. 1983, 48: 2115 -
12f
Bell KH. Aust. J. Chem. 1985, 38: 1209 -
12g
Turner DE.O’Malley RF.Sardella DJ.Barinelli LS.Kaul P. J. Org. Chem. 1994, 59: 7335 -
12h
Boas U.Christensen JB.Jensen KJ. J. Comb. Chem. 2004, 6: 497 -
18a
Kotha S.Mandal K.Tiwari A.Mobin SM. Chem. Eur. J. 2006, 12: 8024 -
18b
Chattopadhyay SK.Ghosh D.Neogi K. Synth. Commun. 2007, 37: 1535 -
21a
Rieche A.Fruhwald E. Ber. Dtsch. Chem. Ges. B 1931, 64: 1603 -
21b
Moghaddam FM.Porkaleh H.Zali-Boeini H. Lett. Org. Chem. 2006, 3: 123
References and Notes
To a solution of 2,7-dimethoxynaphthalene(1) in CH2Cl2 (0.05 M) at 0 ˚C was added propargyl alcohol complex 2 (1.1 equiv for monocondensations, 2.2 equiv for dicondensations) and BF3˙OEt2 (3 equiv). After 3 h of stirring at 0 ˚C, aq NH4Cl was added, and the mixture subjected to a conventional extractive workup. Purification by flash chromatography afforded 3 (monocondensation) or 4 and 5 (dicondensation).
14
Analytical Data
for Selected Compounds
Compound 3a:
IR (KBr): νmax = 3003, 2960, 2090,
2055
cm-¹. ¹H
NMR (500 MHz, CDCl3): δ = 7.71 (d, J = 8.9 Hz, 1
H), 7.70 (d, J = 8.9
Hz, 1 H), 7.22 (d, J = 2.4
Hz, 1 H), 7.10 (d, J = 8.9
Hz, 1 H), 7.04 (dd, J = 8.9,
2.4 Hz, 1 H), 5.95 (s, 1 H), 4.60 (s, 2 H), 3.97 (s, 3 H), 3.94
(s, 3 H). ¹³C NMR (125 MHz, CDCl3): δ = 199.6,
158.4, 154.7, 133.9, 130.2, 128.6, 124.6, 120.1, 116.1, 109.7, 101.6,
96.1, 73.5, 55.4, 55.1, 29.5. MS: m/e = 484 [M+ - CO],
456 [M+ - 2 CO],
428 [M+ - 3 CO],
372 [M+ - 5 CO].
HRMS: m/e calcd for C21H14Co2O8 [M+ - 2
CO]: 455.9454; found: 455.9441.
Compound 3b: IR (KBr): νmax = 3003,
2951, 2097, 2063, 2028, 1708 cm-¹. ¹H
NMR (500 MHz, CDCl3
): δ = 7.72
(d, J = 8.9
Hz, 1 H), 7.68 (d, J = 8.9
Hz, 1 H), 7.18 (d, J = 2.3 Hz,
1 H), 7.10 (d, J = 8.9
Hz, 1 H), 7.02 (dd, J = 8.9,
2.3 Hz, 1 H), 4.64 (s, 2 H), 3.96 (s, 3 H), 3.95 (s, 3 H), 3.53
(s, 3 H). ¹³C NMR (125 MHz,
CDCl3): δ = 198.4, 171.7, 158.5, 154.7, 133.9,
130.1, 128.8, 124.4, 119.1, 116.2, 109.3, 101.1, 99.4, 79.3, 55.2,
54.9, 52.4, 29.0. MS: m/e = 570 [M+],
542 [M+ - 1 CO],
514 [M+ -2 CO], 486 [M+ - 3
CO], 458 [M+ - 4
CO], 430 [M+ - 5
CO], 402 [M+ - 6
CO]. HRMS: m/e calcd
for C23H16Co2O10 [M+ - CO]:
541.9458; found: 541.9455.
However, substitution at the propargylic site in 2 resulted in condensation reactions at C-3 in preference to C-1.
16
Analytical Data
for Selected Compounds
Compound 4a:
IR (KBr): νmax = 2917, 2090, 2051,
2021
cm-¹. ¹H
NMR (500 MHz, CDCl3): δ = 7.70
(d, J = 8.9
Hz, 2 H), 7.12 (d, J = 8.9
Hz, 2 H), 5.83 (s, 2 H), 5.22 (d, J = 16.4 Hz,
2 H), 4.50 (d, J = 16.4
Hz, 2 H), 3.99 (s, 6 H). ¹³C NMR (125
MHz, CDCl3): δ = 199.6, 156.1, 131.9,
130.7, 126.5, 121.3, 110.1, 97.5, 73.8, 55.9, 30.6. MS: m/e = 808 [M+ - 1 CO],
780 [M+ - 2 CO],
752 [M+ - 3 CO],
724 [M+ - 4 CO], 696 [M+ - 5
CO], 668 [M+ - 6
CO], 640 [M+ - 7
CO], 612 [M+ - 8
CO]. HRMS: m/e calcd
for C30H16Co4O14 [M+ - CO]:
807.7917; found: 807.7904.
Compound 4b:
IR (KBr): νmax = 3004, 2950, 2097,
2067, 1710 cm-¹. ¹H
NMR (500 MHz, CDCl3
): δ = 7.71
(d, J = 9.0 Hz,
2 H), 7.10 (d, J = 9.0
Hz, 2 H), 5.19 (d, J = 16.5
Hz, 2 H), 4.69 (d, J = 16.5
Hz, 2 H), 3.40 (s, 6 H), 3.46 (s, 6 H). ¹³C NMR
(125 MHz, CDCl3): δ = 198.2, 170.6,
156.1, 132.1, 131.0, 126.3, 120.3, 109.8, 99.9, 80.3, 55.7, 52.4,
30.9. MS: m/e = 896 [M+ - 2
CO], 840 [M+ - 4
CO], 784 [M+ -6 CO], 728 [M+ - 8
CO], 700 [M+ - 9
CO].
Compound 6:
IR (KBr): νmax = 3291, 2932, 2107,
1618
cm-¹. ¹H
NMR (500 MHz, CDCl3): δ = 7.72
(d, J = 9.0
Hz, 2 H), 7.18 (d, J = 9.0
Hz, 2 H), 4.31 (d, J = 2.6
Hz, 4 H), 4.03 (s, 6 H), 2.16 (t, J = 2.6
Hz, 2 H). ¹³C NMR (125 MHz, CDCl3): δ = 156.7,
133.5, 130.1, 126.2, 117.3, 111.0, 84.7, 69.1, 56.9, 17.3. MS: m/e = 264 [M+].
HRMS: m/e calcd for C18H16O2 [M+] = 264.1150;
found: 264.1153.
Compound 7: IR
(KBr): νmax = 3077, 2934, 1614 cm-¹. ¹H NMR
(300 MHz, CDCl3
): δ = 7.72
(d, J = 8.9
Hz, 2 H), 7.18 (d, J = 8.9
Hz, 2 H), 6.23 (m, 2 H), 5.09 (dd J = 10.3,
1.9 Hz, 2 H), 4.84 (dd, J = 17.3,
1.9 Hz, 2 H), 3.93 (s, 6 H), 3.91 (m, 4 H). ¹³C
NMR (75 MHz, CDCl3
): δ = 156.7,
139.0, 134.9, 129.4, 126.3, 120.4, 114.5, 111.0, 56.8, 30.9. MS: m/e = 268 [M+].
HRMS: m/e calcd for C18H20O2 [M+]:
268.1463; found: 268.1466.
Compound 8:
IR (KBr): νmax = 3033, 2934, 1616 cm-¹. ¹H NMR
(500 MHz, CDCl3
): δ = 7.59
(d, J = 9.0
Hz, 2 H), 7.11 (d, J = 9.0
Hz, 2 H), 6.19 (m, 2 H), 4.02 (d, J = 5.6
Hz, 4 H), 3.92 (s, 6 H). ¹³C NMR (125
MHz, CDCl3
): δ = 153.9,
134.8, 130.9, 128.3, 126.8, 120.2, 111.9, 57.2, 24.2. MS: m/e = 240 [M+].
HRMS: m/e calcd for C16H16O2 [M+]:
240.1150; found: 240.1150.
Analytical Data
for Selected Compounds
Compound 10:
IR (KBr): νmax = 2956, 2233, 1712,
1628
cm-¹. ¹H
NMR (500 MHz, CDCl3): δ = 7.72
(d, J = 9.0
Hz, 1 H), 7.69 (d, J = 8.9
Hz, 1 H), 7.22 (d, J = 2.4
Hz, 1 H), 7.11 (d, J = 9.0
Hz, 1 H), 7.05 (dd, J = 8.9,
2.4 Hz, 1 H), 4.11 (s, 2 H), 3.97 (s, 3 H), 3.96 (s, 3 H), 3.70
(s, 3 H). ¹³C NMR (125 MHz, CDCl3
): δ = 158.4,
154.6, 154.0, 133.7, 129.9, 128.9, 124.3, 116.1, 113.6, 110.1, 101.2,
87.7, 71.9, 56.1, 55.0, 52.2, 14.5. MS: m/e = 284 [M+].
HRMS: m/e calcd for C17H16O4 [M+]:
284.1049; found: 284.1033.
Compound 11:
IR (KBr): νmax = 2954, 1740, 1628 cm-¹. ¹H NMR
(300 MHz, CDCl3): δ = 7.69 (d, J = 8.9 Hz,
1 H), 7.66 (d, J = 8.9
Hz, 1 H), 7.32 (d, J = 2.0
Hz, 1 H), 7.12 (d, J = 8.9 Hz,
1 H), 7.03 (dd, J = 8.9,
2.0 Hz, 1 H), 3.98 (s, 3 H), 3.93 (s, 3 H), 3.70 (s, 3 H), 3.11
(t, J = 7.6
Hz, 2 H), 2.44 (t, J = 7.1
Hz, 2 H), 2.00 (m, 2 H). ¹³C NMR (75
MHz, CDCl3
): δ = 174.0,
158.1, 154.8, 134.1, 129.8, 127.3, 124.5, 121.2, 115.7, 110.2, 101.6,
55.9, 55.1, 51.2, 33.4, 24.2, 24.1. MS: m/e = 288 [M+].
HRMS: m/e calcd for C17H20O4 [M+]: 288.1362;
found: 288.1360.
Compound 13:
IR (KBr): νmax = 3422 (br), 2966, 1627
cm-¹. ¹H NMR (500 MHz, CDCl3): δ = 7.70
(d, J = 8.9
Hz, 1 H), 7.66 (d, J = 8.9
Hz, 1 H), 7.24 (d, J = 2.3
Hz, 1 H), 7.13 (d, J = 8.9
Hz, 1 H), 7.05 (dd, J = 8.9,
2.3 Hz, 1 H), 3.952 (s, 3 H), 3.945 (s, 3 H), 3.09 (t, J = 7.6 Hz,
2 H), 1.75 (m, 2 H), 1.69 (m, 2 H) 1.38 (br s, 1 H), 1.23 (s, 6
H). ¹³C NMR (75 MHz, CDCl3): δ = 158.0,
154.8, 134.1, 130.0, 127.1, 124.7, 122.6, 115.5, 110.8, 102.0, 70.9,
56.3, 55.1, 43.8, 29.1, 25.4, 24.4. MS: m/e = 288 [M+].
HRMS: m/e calcd for C18H24O3 [M+]:
288.1725; found: 288.1713.
Compound 9:
IR (KBr): νmax = 2929, 1612 cm-¹. ¹H
NMR (500 MHz, CDCl3
): δ = 7.54
(d, J = 8.9
Hz, 1 H), 7.52 (d, J = 8.8
Hz, 1 H), 7.09 (d, J = 8.9
Hz, 1 H), 7.07 (d, J = 8.8 Hz,
1 H), 3.95 (s, 3 H), 3.92 (s, 3 H), 3.00 (br m, 2 H), 1.96 (m, 2
H), 1.70 (m, 2 H), 1.52 (s, 6 H). ¹³C
NMR (125 MHz, CDCl3
): δ = 158.8,
154.5, 137.6, 131.7, 127.3, 126.9, 125.4, 122.9, 112.1, 111.6, 84.6,
57.4, 56.0, 41.1, 39.4, 25.5, 22.1. MS: m/e = 270 [M+].
HRMS: m/e calcd for C18H22O2 [M+]: 270.1620;
found: 270.1614.
Analytical Data
for Selected Compounds
Compound 17:
IR (KBr): νmax = 3004, 2952, 2099,
2063, 2029,1765, 1709 cm-¹. ¹H
NMR (500 MHz, CDCl3
): δ = 7.82
(d, J = 9.0
Hz, 1 H), 7.81 (d, J = 8.8
Hz, 1 H) 7.61 (d, J = 2.2
Hz, 1 H), 7.26 (d, J = 9.0
Hz, 1 H), 7.11 (dd, J = 8.8, 2.2
Hz, 1 H), 4.60 (s, 2 H), 3.96 (s, 3 H), 3.75 (s, 3 H), 2.33 (s,
3 H). ¹³C NMR (125 MHz, CDCl3): δ = 198.0,
170.5, 169.4, 154.7, 149.3, 133.2, 130.0, 128.8, 126.8, 120.0, 118.6,
114.1, 111.8, 98.5, 93.9, 55.2, 52.5, 28.2, 20.8. MS: m/e = 542 [M+ - 2
CO], 514 [M+ - 3
CO], 486 [M+ - 4
CO], 458 [M+ - 5
CO], 430 [M+ - 6
CO]. HRMS: m/e calcd
for C24H16Co2O11 [M+ - 3
CO]: 513.9509; found: 513.9511.
Compound 18: IR (KBr). νmax = 2917,
2234, 1761, 1712 cm-¹. ¹H
NMR (500 MHz, CDCl3): δ = 7.81 (d, J = 8.9 Hz,
2 H), 7.62 (d, J = 2.1
Hz, 1 H), 7.26 (d, J = 8.9
Hz, 1 H), 7.15 (dd. J = 8.8,
2.1 Hz, 1 H), 4.08 (s, 2 H), 3.99 (s, 3 H), 3.71 (s, 3 H), 2.38
(s, 3 H). ¹³C NMR (75 MHz, CDCl3
): δ = 169.4, 154.7,
154.0, 149.4, 133.1, 129.9, 129.2, 126.9, 118.8, 114.8, 113.7, 112.7,
87.4, 72.0, 56.3, 52.3, 21.0, 14.6. MS: m/e = 312 [M+].
HRMS: m/e calcd for C18H16O5 [M+]: 312.0998;
found: 312.0991.
Compound 19:
IR (KBr): νmax 3067, 2950, 1759, 1734 cm-¹. ¹H
NMR (500 MHz, CDCl3
): δ = 7.75
(d, J = 8.8
Hz, 1 H), 7.67 (d, J = 1.9
Hz, 1 H), 7.65 (d, J = 9.0
Hz, 1 H), 7.16 (d, J = 9.0
Hz, 1 H), 7.09 (dd, J = 8.8,
1.9 Hz, 1 H), 3.85 (s, 3 H), 3.64 (s, 3 H), 3.08 (t, J = 17.6 Hz,
2 H), 2.39 (t, J = 7.4 Hz,
2 H), 2.33 (s, 3 H), 1.99 (m, 2 H). ¹³C
NMR (125 MHz, CDCl3): δ = 173.9, 169.5,
154.9, 149.1, 133.6, 129.9, 127.6, 127.1, 122.3, 118.4, 114.0, 112.7,
56.1, 51.2, 33.5, 24.7, 24.0, 21.1. MS: m/e = 316 [M+].
HRMS: m/e calcd for C18H20O5 [M+]:
316.1311; found: 316.1316.
Compound 20:
IR (KBr): νmax = 3385 (br), 2924, 1703,
1626 cm-¹. ¹H NMR
(500 MHz, acetone-d
6): δ = 7.63
(d, J = 8.8 Hz,
1 H), 7.62 (d, J = 9.0
Hz, 1 H), 7.28 (br s, 1 H), 7.11 (d, J = 9.0
Hz, 1 H), 6.93 (dd, J = 8.8,
2.1 Hz, 1 H), 3.87 (s, 3 H), 2.99 (t, J = 7.7
Hz, 2 H), 2.35 (m, 2 H), 1.85 (m, 2 H). ¹³C
NMR (125 MHz, acetone-d
6): δ = 174.5,
156.0, 155.1, 134.8, 130.2, 127.7, 124.5, 120.7, 115.7, 110.3, 104.8,
55.8, 33.3, 24.8, 24.1. MS: m/e = 260 [M+].
HRMS: m/e calcd for C15H16O4 [M+]:
260.1049; found: 260.1045.
Compound 15:
IR (KBr): νmax = 3009, 2970, 1616 cm-¹.
¹H
NMR (500 MHz, CDCl3): δ = 12.73 (s,
1 H), 7.71 (d, J = 8.9
Hz, 1 H), 7.63 (d, J = 8.8
Hz, 1 H), 7.12 (d, J = 8.8 Hz,
1 H), 6.93 (d, J = 8.9
Hz, 1 H), 3.95 (s, 3 H), 3.01 (t, J = 7.1
Hz, 2 H), 2.71 (t, J = 7.4
Hz, 2 H), 2.39 (m, 2 H). ¹³C NMR (125
MHz, CDCl3): δ = 207.4, 162.5, 157.3,
136.2, 135.7, 128.6, 123.2, 122.3, 116.5, 115.2, 110.3, 56.2, 42.3, 29.5,
25.4. MS: m/e = 242 [M+].
HRMS: m/e calcd for C15H14O3 [M+]:
242.0943; found: 242.0931.
Analytical Data
for Selected Compounds
Compound 21:
IR (KBr): νmax = 3358, 2967 cm-¹. ¹H
NMR (500 MHz, CDCl3): δ = 8.10 (br
s, 1 H), 7.65 (d, J = 8.8
Hz, 1 H), 7.61 (d, J = 8.9
Hz, 1 H), 7.33 (d, J = 2.2
Hz, 1 H), 7.08 (d, J = 8.9
Hz, 1 H), 7.01 (dd, J = 8.8,
2.2 Hz, 1 H), 3.91 (s, 3 H), 2.95 (br t, J = 7.0
Hz, 2 H), 2.60 (br s, 1 H), 1.65 (m,
4 H), 1.21 (s, 6
H). ¹³C NMR (125 MHz, CDCl3): δ = 154.6, 154.5,
134.4, 130.3, 127.3, 124.5, 122.1, 115.6, 110.7, 105.3, 72.0, 56.4,
43.5, 29.1, 25.4, 24.3. MS: m/e = 274 [M+]. HRMS: m/e calcd for C17H22O3:
274.1569; found: 274.1574.
Compound 22:
IR (KBr): νmax = 2934, 1653, 1615 cm-¹. ¹H NMR
(500 MHz, CDCl3): δ = 7.29 (d, J = 9.7 Hz,
1 H), 7.13 (d, J = 8.4
Hz, 1 H), 6.79 (d, J = 8.4
Hz, 1 H), 5.97 (d, J = 9.7 Hz,
1 H), 3.84 (s, 3 H), 3.63 (s, 1 H), 3.36 (m, 1 H), 2.42 (m, 1 H),
1.84 (m, 1 H), 1.51 (m, 1 H), 1.38 (m, 1 H), 1.27 (m, 1 H), 1.17
(s, 3 H), 0.66 (s, 3 H). ¹³C NMR (125
MHz, CDCl3): δ = 203.2, 157.7, 145.5,
140.8, 129.4, 127.9, 124.4, 123.5, 108.9, 58.3, 55.7, 43.2, 37.0,
27.4, 24.2, 21.5, 20.2. MS: m/e 256 [M+].
HRMS: m/e calcd for C17H20O2:
256.1463; found: 256.1457.